App-Quantinova.ai

Frequency of Intracranial Arterial Imaging and its Yield in Consecutive Patients with Non-lacunar Cryptogenic Ischemic Stroke: ESUS Global Registry

Balakumar Swaminathan - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ischemic stroke

N/A

Did Race Impact Risk Factor Control in the SAMMPRIS Trial?

Tanya N. Turan - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Coronary Artery Disease

N/A

Improving Stroke Door-to-Needle Time Through a Recognition Program

Isabelle Martineau - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Characteristics and Outcomes Among Patients Transferred to Regional Stroke Centers Across the United States for Specialized Stroke Care

Gregg Fonarow - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypertension

N/A

International Comparison of Patient Characteristics and Performance Measures in Acute Ischemic Stroke: Analysis of the American Heart Association Get With the Guidelines-Stroke Registry and China National Stroke Registry

Zixiao Li - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Current Use of Strategies to Improve Door-to-Needle Times With Tissue Plasminogen Activator in Acute Ischemic Stroke: Findings From the Target: Stroke Phase II Survey

Barbara Lytle - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Influence of Aversion to Uncertainty in STROKE Care

Lauren Crump - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Tracts Enfolded by Small Hematomas Remain Intact in Acute Intracerebral Hemorrhage

Taurian Guinand - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Intracerebral hemorrhage

N/A

Early Comfort Care Measures in Acute Stroke Patients: Analysis From the Get With the Guidelines Stroke Registry

Margueritte Cox - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Subarachnoid hemorrhage

N/A

Improving Stroke Rehabilitation Intensity Data Collection: Collaborative Implementation of a Quality Assurance Framework

Donna Cheung - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Antithrombotic Therapy in Patients With Atrial Fibrillation and Prior Stroke in GLORIA- AF Phase II (Global Registry on Long-term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation, Phase II)

Menno V Huisman - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

N/A

Regional Assessment of Multi-phase CTA and CT Perfusion are Equivalent in Predicting Tissue Fate in Ischemic Stroke

Anurag Trivedi - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Eloquence-Weighted Imaging Improves Clinical Outcomes Prediction in Endovascular Stroke Therapy

David S. Liebeskind - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Use of Intravenous Tissue Plasminogen Activator in Patients Without a Stroke (Stroke Mimics): Findings From the get With the Guidelines Stroke Registry

Jerome J Federspiel - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Transient Ischemic Attack

N/A

Predictive Value of Rapid-assessed Cerebral Blood Volume and Cerebral Blood Flow Ct Perfusion Thresholds on Final Infarct Volume Following Successful Reperfusion: Analysis of The SWIFT PRIME Trial Data

Elad Levy - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

Variation in the Rates of Acute Ischemic Stroke Transfers Between Hospitals in the United States

Gregg Fonarow - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Rivaroxaban Therapy Is Not Associated with Hemorrhagic Transformation After Acute Cardioembolic Stroke: A Prospective MRI Study

Mahesh Kate - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

rivaroxaban

Estimated Glomerular Filtration Rate Decreases Transiently After Stroke in Patients With Atrial Fibrillation

Keith Phoa - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Chronic kidney disease

N/A

Identifying Modifiable Predictors of Long-term Functional Outcome After Stroke

Richard Swartz - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Depression

N/A

Increased Risky Driving in Acute Compared to Chronic Ischemic Stroke Drivers

Kristin A Vesely - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Ischemic stroke

N/A

Filters

28841 Abstracts